Jian Jun left a state-owned trading career, spent years working overseas and then helped build Imeik into a leading Chinese medical-aesthetics company, ultimately becoming its controlling shareholder and chairwoman before the company's 2020 Shenzhen listing. [1][2][3]
Her career moved from state employment into a long, hands-on company-building path
Forbes says Jian began her career at the state-owned China National Cereals Oils and Foodstuffs Import and Export organization, while Chinese securities filings document later work overseas before she became deeply involved in the company that became Imeik. [1][2]
The official IPO response records Jian as a director from 2004, deputy general manager from 2005 to 2011 and chairwoman from 2011 onward, showing a long operating role across the company's development rather than a late passive investment. [2]
Imeik's company materials date its establishment to 2004 and describe a business focused on internally developed biomedical materials and aesthetic products, including injectable fillers and facial threads. [3]
Control and product development turned that operating role into substantial equity value
Securities filings show that Jian became Imeik's controlling shareholder in 2011 through share transfers and additional capital, before the company eventually listed in Shenzhen in 2020 and created a large public-market value for her retained stake. [2][1]
The reviewed evidence therefore supports a primarily self-created fortune: Jian did not inherit a major operating business, and her wealth is tied to years of management, capital commitment and product commercialization at Imeik, even though the company's early ownership history involved other family members and partners. [2][1][3]
Sources for background
Sources reviewed Oct 5, 2026.
- Jian Jun · Forbes · Mar 10, 2026
- Imeik IPO sponsor work report · CNINFO · Sep 9, 2020
- Company Profile · IMEIK
Comparable Healthcare billionaires
Similar Healthcare billionaires by estimated net worth.
